Stock Research for BNIKF

BNIKF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BNIKF Stock Chart & Research Data

The BNIKF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BNIKF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BNIKF Due diligence Resources & Stock Charts

The BNIKF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BNIKF Detailed Price Forecast - CNN Money CNN View BNIKF Detailed Summary - Google Finance
Yahoo View BNIKF Detailed Summary - Yahoo! Finance Zacks View BNIKF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BNIKF Trends & Analysis - Trade-Ideas Barrons View BNIKF Major Holders - Barrons
NASDAQ View BNIKF Call Transcripts - NASDAQ Seeking View BNIKF Breaking News & Analysis - Seeking Alpha
Spotlight View BNIKF Annual Report - CompanySpotlight.com OTC Report View BNIKF OTC Short Report - OTCShortReport.com
TradeKing View BNIKF Fundamentals - TradeKing Charts View BNIKF SEC Filings - Bar Chart
WSJ View Historical Prices for BNIKF - The WSJ Morningstar View Performance/Total Return for BNIKF - Morningstar
MarketWatch View the Analyst Estimates for BNIKF - MarketWatch CNBC View the Earnings History for BNIKF - CNBC
StockMarketWatch View the BNIKF Earnings - StockMarketWatch MacroAxis View BNIKF Buy or Sell Recommendations - MacroAxis
Bullish View the BNIKF Bullish Patterns - American Bulls Short Pains View BNIKF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BNIKF Stock Mentions - StockTwits PennyStocks View BNIKF Stock Mentions - PennyStockTweets
Twitter View BNIKF Stock Mentions - Twitter Invest Hub View BNIKF Investment Forum News - Investor Hub
Yahoo View BNIKF Stock Mentions - Yahoo! Message Board Seeking Alpha View BNIKF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BNIKF - SECform4.com Insider Cow View Insider Transactions for BNIKF - Insider Cow
CNBC View BNIKF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BNIKF - OTC Markets
Yahoo View Insider Transactions for BNIKF - Yahoo! Finance NASDAQ View Institutional Holdings for BNIKF - NASDAQ


Stock Charts

FinViz View BNIKF Stock Insight & Charts - FinViz.com StockCharts View BNIKF Investment Charts - StockCharts.com
BarChart View BNIKF Stock Overview & Charts - BarChart Trading View View BNIKF User Generated Charts - Trading View




Latest Financial News for BNIKF


3 Biotech Stocks That Soared This Week: Are They Buys?
Posted on Saturday July 14, 2018

Can these hot biotech stocks get even hotter?


Axovant, Benitec Gain on Licensing Deal for Gene Therapy
Posted on Tuesday July 10, 2018

Axovant Sciences' (AXON) shares gain, following the news of a licensing deal for oculopharyngeal muscular dystrophy candidate with Benitec Biopharma.


Axovant and Benitec Biopharma Up on Gene Therapy Development Deal
Posted on Monday July 09, 2018

Axovant and Benitec Biopharma Rise on Gene Therapy Licensing DealAxovant and Benitec Biopharma enter into a licensing deal


Axovant, Benetic Jump on Agreement to Develop Gene Therapy for MD
Posted on Monday July 09, 2018

Shares of the biopharmaceutical company rose 5% in early morning trading Monday after it announced it had bought the rights to a new gene therapy treatment designed for a rare form of muscular dystrophy from Benitec Biopharma Ltd. Axovant rose 12 cents -- or 5% -- to $2.68 a share on news of the deal while Benitec skyrocketed $1.52 -- or 67.8% --$3.76. The two companies also entered into a research collaboration to develop five more treatments meant to target neurological disorders.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.